Venus Remedies gets marketing approval for six chemotherapy drugs from the Philippines
Venus Remedies' oncology wing has also secured marketing authorisation from Myanmar for another chemotherapy drug
Venus Remedies' oncology wing has also secured marketing authorisation from Myanmar for another chemotherapy drug
Jemperli is the only immuno-oncology treatment approved in the frontline setting for this patient population in combination with chemotherapy
For the treatment of Superficial Femoral Artery
Company intends to increase sales in the UK to approximately 2 million Euros by focusing on seven molecules which are already registered in the country
The marketing authorisations for three generic drugs signifying advances in cancer treatment will considerably benefit thousands of patients by improving access, ensuring affordability
The yoga protocol included gentle and restorative yoga postures(asana) with regular periods of relaxation and pranayama
Results showed a statistically significant and clinically meaningful improvement in investigator-assessed progression-free survival
Destiny-Breast11 will evaluate Enhertu as a monotherapy or Enhertu followed by paclitaxel, trastuzumab and pertuzumab
Roche is notifying healthcare professionals and patients in the US about this withdrawal. Patients being treated with Tecentriq for PD-L1-positive mTNBC should discuss their care with their healthcare provider
Besides powering the drug discovery efforts, phytopharmaceuticals have a huge potential to create a niche market for itself, thereby helping to expand the bio-economy.
Subscribe To Our Newsletter & Stay Updated